- PMID 37106136. Egbuna, Ogo; Zimmerman, Brandon; Manos, George; Fortier, Anne;
Chirieac,
Madalina C.; Dakin,
Leslie A.; Friedman,
David J.; Bramham, Kate; Campbell...
- 1
March 2018.
Richards WG,
Zellos L,
Bueno R,
Jaklitsch MT, Jänne PA,
Chirieac LR, et al. (April 2006). "Phase I to II
study of pleurectomy/decortication...
-
Retrieved 28
January 2014. Li D,
Ambrogio L,
Shimamura T, Kubo S,
Takahashi M,
Chirieac LR, et al. (August 2008). "BIBW2992, an
irreversible EGFR/HER2 inhibitor...
- doi:10.1038/nature05945. PMID 17625570. S2CID 2172543.
Sasaki T,
Rodig SJ,
Chirieac LR, Jänne PA (July 2010). "The
biology and
treatment of EML4-ALK non-small...
- Nicholson,
Andrew G.; Yatabe, Yasushi; Austin, John H.M.; Beasley, Mary Beth;
Chirieac, Lucian. R.; Dacic, Sanja; Duhig,
Edwina (2015). "The 2015
World Health...
-
Travis WD,
Brambilla E,
Nicholson AG,
Yatabe Y,
Austin JH,
Beasley MB,
Chirieac LR,
Dacic S,
Duhig E,
Flieder DB,
Geisinger K,
Hirsch FR,
Ishikawa Y, Kerr...
- 2016-04-05.
Laury AR,
Perets R, Piao H,
Krane JF,
Barletta JA,
French C,
Chirieac LR, Lis R, Loda M,
Hornick JL,
Drapkin R,
Hirsch MS (June 2011). "A comprehensive...
- PMID 18026190. Li, D; Ambrogio, L; Shimamura, T; Kubo, S; Takahashi, M;
Chirieac, L R; Padera, R F; Shapiro, G I; et al. (2008). "BIBW2992, an irreversible...
-
Oncology Drug Products. "FDA
Approval for Crizotinib".
Sasaki T,
Rodig SJ,
Chirieac LR, Jänne PA (July 2010). "The
biology and
treatment of EML4-ALK non-small...
- J,
Solis LM,
Wistuba II,
Barletta JA,
Gandhi L,
Feldman HA,
Rodig SJ,
Chirieac LR,
Zetter BR (May 2010). "Collagen XXIII: a
potential biomarker for the...
